LEMUREN AS

Signals

2 flags

• ▼ Negativ egenkapital 2025 Bokført egenkapital er negativ (−252k kr).
• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−13k kr).

LEMUREN AS is registered as a limited company in Oslo, Oslo with organisation number 926493728. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2021. Registered share capital is NOK 30,000, divided into 3000 shares. The company's stated purpose is: “Holdingselskap for Bjørn Klem sine aksjer i Adjutec Pharma AS.”.

Former names: NFH 210198 AS

Key figures · 2025

Operating profit

NOK −13,000

▼ −9 %

Equity

NOK −252,000

▼ −18 %

Financial health · 2025

Liquidity

–

Not available

Current assets ÷ current liabilities

Profitability

-0.8%

Not satisfactory

Return on total assets

Solidity

-29.3%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns LEMUREN AS?

Bjørn Klem Private shareholder

100.0%

LEMUREN AS

· NOK −13,000 profit

LEMUREN AS has 1 registered shareholder:

• Bjørn Klem 100.0%

All shareholders and roles →

Which companies does LEMUREN AS own?

LEMUREN AS holds a stake in 1 company:

• ADJUTEC PHARMA AS 2.3%

See the full ownership structure →

Frequently asked questions about LEMUREN AS

Who owns LEMUREN AS?

Bjørn Klem is the largest registered owner, with 100.0%.

Who is the general manager of LEMUREN AS?

Bjørn Klem is registered as general manager of LEMUREN AS.

Where is LEMUREN AS based?

LEMUREN AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.